Search for: "Novartis Vaccines and Diagnostics, Inc."
Results 21 - 40
of 41
Sorted by Relevance
|
Sort by Date
23 Aug 2011, 2:46 pm
-Appellant’s Reply Br. at 10; see also Compl. at 1, Novartis Vaccines & Diagnostics, Inc. v. [read post]
27 Oct 2009, 12:47 am
Novartis Vaccines and Diagnostics Inc., 1-08-cv-00290 (DED October 23, 2009, Order) (Robinson, J.) [read post]
17 Aug 2012, 10:29 am
Prior to that, her career included a variety of legal positions with Chiron Corporation and Novartis Vaccines and Diagnostics, Inc., and a partnership at the Farella, Braun & Martel law firm in San Francisco. [read post]
24 Jan 2012, 6:34 pm
District Court for the Northern District of Illinois (Eastern Division), the court denied Plaintiffs’ Seattle Children’s Hospital, Novartis Vaccines and Diagnostics, Inc., and Novartis Pharmaceuticals Corporation (collectively “Novartis”) Motion to Dismiss the lawsuit that they brought against Akorn, Inc. [read post]
22 Jul 2010, 10:11 am
This case is distinguishable from Novartis Vaccines & Diagnostics, Inc. v. [read post]
21 Jul 2011, 8:47 am
Though in Novartis Vaccines & Diagnostics, Inc. v. [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
2 Mar 2012, 6:52 am
Aventis (flu vaccine) Deposition2006-08-18 Weston v. [read post]
9 Aug 2012, 5:00 am
Aventis (flu vaccine) Deposition2006-08-18 Weston v. [read post]
16 Dec 2009, 3:39 am
(Patent Docs) Crestor (Rosuvastatin) –US: AstraZeneca fails to win summary judgment in Crestor patent battle against Apotex and others (GenericsWeb) Cubicin (Daptomycin) – US: Trial date set Cubicin patent litigation against Teva (GenericsWeb) Effexor (Venlafaxine) – US: Settlement announced in Effexor XR patent infringement dispute between Pfizer and Mylan (Patent Docs) (BioSpace) Hexilate, Kogenate (Recombinant factor VIII) – US: Novartis Vaccines and… [read post]
18 Oct 2010, 5:51 pm
Genentech, 566 F.3d at 1344; see also Novartis Vaccines and Diagnostics, Inc. v. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
25 Feb 2012, 10:04 am
Novartis Pharm. [read post]
24 Feb 2010, 2:11 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent… [read post]
9 May 2012, 2:28 pm
Koch was deputy general counsel of Chiron Corp. and its successor Novartis Vaccines and Diagnostics, Inc. [read post]
24 Feb 2010, 2:11 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent… [read post]
7 May 2009, 6:08 am
Novartis Pharmaceuticals Corp., 252 F.3d 986, 990 (8th Cir. 2001); Hans v. [read post]
23 Jun 2014, 12:57 pm
Biomarkers, other than diagnostic criteria, rarely point to a specific cause(s) in a given case. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
